Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

Aliki Xochelli, Andreas Agathangelidis, Ioannis Kavakiotis, Evangelia Minga, Lesley Ann Sutton, Panagiotis Baliakas, Ioanna Chouvarda, Véronique Giudicelli, Ioannis Vlahavas, Nikos Maglaveras, Lisa Bonello, Livio Trentin, Alessandra Tedeschi, Panagiotis Panagiotidis, Christian Geisler, Anton W. Langerak, Sarka Pospisilova, Diane F Jelinek, David Oscier, Nicholas ChiorazziNikos Darzentas, Fred Davi, Paolo Ghia, Richard Rosenquist, Anastasia Hadzidimitriou, Chrysoula Belessi, Marie Paule Lefranc, Kostas Stamatopoulos

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Νext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.

Original languageEnglish (US)
Pages (from-to)61-66
Number of pages6
JournalImmunogenetics
Volume67
Issue number1
DOIs
StatePublished - 2014

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Directories
Immunogenetics
Names
Immunoglobulins
Information Systems
Alleles
Research
Genes
Research Personnel
Physicians

Keywords

  • CLL
  • New IGHV gene alleles
  • New IGHV genes
  • Prognostication
  • SHM

ASJC Scopus subject areas

  • Immunology
  • Genetics
  • Medicine(all)

Cite this

Immunoglobulin heavy variable (IGHV) genes and alleles : new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia. / Xochelli, Aliki; Agathangelidis, Andreas; Kavakiotis, Ioannis; Minga, Evangelia; Sutton, Lesley Ann; Baliakas, Panagiotis; Chouvarda, Ioanna; Giudicelli, Véronique; Vlahavas, Ioannis; Maglaveras, Nikos; Bonello, Lisa; Trentin, Livio; Tedeschi, Alessandra; Panagiotidis, Panagiotis; Geisler, Christian; Langerak, Anton W.; Pospisilova, Sarka; Jelinek, Diane F; Oscier, David; Chiorazzi, Nicholas; Darzentas, Nikos; Davi, Fred; Ghia, Paolo; Rosenquist, Richard; Hadzidimitriou, Anastasia; Belessi, Chrysoula; Lefranc, Marie Paule; Stamatopoulos, Kostas.

In: Immunogenetics, Vol. 67, No. 1, 2014, p. 61-66.

Research output: Contribution to journalArticle

Xochelli, A, Agathangelidis, A, Kavakiotis, I, Minga, E, Sutton, LA, Baliakas, P, Chouvarda, I, Giudicelli, V, Vlahavas, I, Maglaveras, N, Bonello, L, Trentin, L, Tedeschi, A, Panagiotidis, P, Geisler, C, Langerak, AW, Pospisilova, S, Jelinek, DF, Oscier, D, Chiorazzi, N, Darzentas, N, Davi, F, Ghia, P, Rosenquist, R, Hadzidimitriou, A, Belessi, C, Lefranc, MP & Stamatopoulos, K 2014, 'Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia', Immunogenetics, vol. 67, no. 1, pp. 61-66. https://doi.org/10.1007/s00251-014-0812-3
Xochelli, Aliki ; Agathangelidis, Andreas ; Kavakiotis, Ioannis ; Minga, Evangelia ; Sutton, Lesley Ann ; Baliakas, Panagiotis ; Chouvarda, Ioanna ; Giudicelli, Véronique ; Vlahavas, Ioannis ; Maglaveras, Nikos ; Bonello, Lisa ; Trentin, Livio ; Tedeschi, Alessandra ; Panagiotidis, Panagiotis ; Geisler, Christian ; Langerak, Anton W. ; Pospisilova, Sarka ; Jelinek, Diane F ; Oscier, David ; Chiorazzi, Nicholas ; Darzentas, Nikos ; Davi, Fred ; Ghia, Paolo ; Rosenquist, Richard ; Hadzidimitriou, Anastasia ; Belessi, Chrysoula ; Lefranc, Marie Paule ; Stamatopoulos, Kostas. / Immunoglobulin heavy variable (IGHV) genes and alleles : new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia. In: Immunogenetics. 2014 ; Vol. 67, No. 1. pp. 61-66.
@article{1382ce238e234c3da73372339b8a20d0,
title = "Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia",
abstract = "Νext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 {\%} of the cohort). In 291/405 sequences (71.9 {\%}), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity ({\%}GI) was noted in 114/405 (28.1 {\%}) sequences; in 50/114 (43.8 {\%}) sequences, changes in the {\%}GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 {\%}, where caution is warranted.",
keywords = "CLL, New IGHV gene alleles, New IGHV genes, Prognostication, SHM",
author = "Aliki Xochelli and Andreas Agathangelidis and Ioannis Kavakiotis and Evangelia Minga and Sutton, {Lesley Ann} and Panagiotis Baliakas and Ioanna Chouvarda and V{\'e}ronique Giudicelli and Ioannis Vlahavas and Nikos Maglaveras and Lisa Bonello and Livio Trentin and Alessandra Tedeschi and Panagiotis Panagiotidis and Christian Geisler and Langerak, {Anton W.} and Sarka Pospisilova and Jelinek, {Diane F} and David Oscier and Nicholas Chiorazzi and Nikos Darzentas and Fred Davi and Paolo Ghia and Richard Rosenquist and Anastasia Hadzidimitriou and Chrysoula Belessi and Lefranc, {Marie Paule} and Kostas Stamatopoulos",
year = "2014",
doi = "10.1007/s00251-014-0812-3",
language = "English (US)",
volume = "67",
pages = "61--66",
journal = "Immunogenetics",
issn = "0093-7711",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Immunoglobulin heavy variable (IGHV) genes and alleles

T2 - new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

AU - Xochelli, Aliki

AU - Agathangelidis, Andreas

AU - Kavakiotis, Ioannis

AU - Minga, Evangelia

AU - Sutton, Lesley Ann

AU - Baliakas, Panagiotis

AU - Chouvarda, Ioanna

AU - Giudicelli, Véronique

AU - Vlahavas, Ioannis

AU - Maglaveras, Nikos

AU - Bonello, Lisa

AU - Trentin, Livio

AU - Tedeschi, Alessandra

AU - Panagiotidis, Panagiotis

AU - Geisler, Christian

AU - Langerak, Anton W.

AU - Pospisilova, Sarka

AU - Jelinek, Diane F

AU - Oscier, David

AU - Chiorazzi, Nicholas

AU - Darzentas, Nikos

AU - Davi, Fred

AU - Ghia, Paolo

AU - Rosenquist, Richard

AU - Hadzidimitriou, Anastasia

AU - Belessi, Chrysoula

AU - Lefranc, Marie Paule

AU - Stamatopoulos, Kostas

PY - 2014

Y1 - 2014

N2 - Νext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.

AB - Νext generation sequencing studies in Homo sapiens have identified novel immunoglobulin heavy variable (IGHV) genes and alleles necessitating changes in the international ImMunoGeneTics information system (IMGT) GENE-DB and reference directories of IMGT/V-QUEST. In chronic lymphocytic leukaemia (CLL), the somatic hypermutation (SHM) status of the clonotypic rearranged IGHV gene is strongly associated with patient outcome. Correct determination of this parameter strictly depends on the comparison of the nucleotide sequence of the clonotypic rearranged IGHV gene with that of the closest germline counterpart. Consequently, changes in the reference directories could, in principle, affect the correct interpretation of the IGHV mutational status in CLL. To this end, we analyzed 8066 productive IG heavy chain (IGH) rearrangement sequences from our consortium both before and after the latest update of the IMGT/V-QUEST reference directory. Differences were identified in 405 cases (5 % of the cohort). In 291/405 sequences (71.9 %), changes concerned only the IGHV gene or allele name, whereas a change in the percent germline identity (%GI) was noted in 114/405 (28.1 %) sequences; in 50/114 (43.8 %) sequences, changes in the %GI led to a change in the mutational set. In conclusion, recent changes in the IMGT reference directories affected the interpretation of SHM in a sizeable number of IGH rearrangement sequences from CLL patients. This indicates that both physicians and researchers should consider a re-evaluation of IG sequence data, especially for those IGH rearrangement sequences that, up to date, have a GI close to 98 %, where caution is warranted.

KW - CLL

KW - New IGHV gene alleles

KW - New IGHV genes

KW - Prognostication

KW - SHM

UR - http://www.scopus.com/inward/record.url?scp=84923646196&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923646196&partnerID=8YFLogxK

U2 - 10.1007/s00251-014-0812-3

DO - 10.1007/s00251-014-0812-3

M3 - Article

C2 - 25388851

AN - SCOPUS:84923646196

VL - 67

SP - 61

EP - 66

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 1

ER -